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Anhedonia (defined as the inability to experience pleasure) is a symptom that is 
difficult to treat in patients with Major Depressive Disorder (MDD).   Prior research 
suggests that the left dorsolateral prefrontal cortex (DLPFC) is a major underlying 
mechanism in the pathophysiology of depression.  Therefore, we investigated whether 
repetitive transcranial magnetic stimulation (rTMS) treatment to the left DLPFC would 
predict a reduction in one facet of anhedonia symptomatology—namely, reward derived 
from positive social stimuli (i.e., smiling human faces)—in 26 depressed adults. The 
results revealed no significant effects of rTMS treatment on either accuracy or speeded 
reaction time during a novel behavioral task that involved identifying positive emotion in 
human faces.  This suggests that although rTMS may be an innovative technique to 
reduce depressive symptoms in adults with MDD overall, its efficacy may not hinge on a 
meaningful reduction in this particular aspect of anhedonia. 
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1 INTRODUCTION 
Depression is a common mental disorder and is the leading cause of disability 
worldwide, affecting more than 300 million people of all ages (WHO, 2018). Anhedonia, 
defined as the reduced capacity to experience pleasure, is a symptom present in 
several different types of psychiatric disorders and has been recognized as a core 
feature of depression (Romney & Candido, 2011; Leventhal et al., 2006). In fact, 
anhedonia has been hypothesized to be a prodrome, and thus a predictor, for the later 
development of depressive disorder across multiple age groups (Loas, 1996; 
Gudmundsen et al., 2018). Anhedonia is a particularly difficult symptom to treat, as prior 
evidence suggests that first-line pharmacotherapies, such as selective serotonin 
reuptake inhibitors (SSRIs), do not adequately address hedonic deficits in depression 
(Treadway & Zald, 2011). 
The prevalence of anhedonia in depression may be driven by at least two factors.  
First, individuals with depression are generally biased toward processing negative 
stimuli faster and more efficiently than positive stimuli (Beck, 1972). Specifically, Beck’s 
Cognitive Triad theory postulates that depressed individuals engage in negatively-
biased thinking that influences the way they view themselves, the world, and their 
future.  Their lived experiences and schemas become filtered by their negative 
automatic cognitions, which affects the way they attend to and process information in 
their environment (Beck, 1967).  It is thought that the negative schemas and attitudes 
held by individuals who are currently depressed and/or are susceptible to depression 
are maintained by activation of the cognitive triad, which can result in myriad depression 
symptoms, such as fatigue, amotivation, and anhedonia (Leahy & Dowd, 2002).   
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However, it is also possible that a more direct deficit in positive affectivity itself may 
also contribute to the emergence of anhedonia.  For example, it may not be just a 
matter of not attending as well to positive stimuli, but a deficit in the actual interpretation 
of hedonic information may also exist.  This possibility is based on a growing literature 
that suggests that individuals with depression do not always derive the same hedonic 
value from positive stimuli as healthy controls, even when their general attention is 
focused appropriately.   
Previous research investigating anhedonia in depression has shown significantly 
reduced responsiveness to, and appraisal of, reward values (Gorwood, 2008).  For 
example, a neuroimaging study conducted by Heller et al. (2009) found that depressed 
individuals demonstrated a reduction in activation in the nucleus accumbens (NAcc), 
which, along with the fronto-striatal network, is implicated in reward appraisal and 
motivation, over time during a positive affect evoking task compared to controls.  These 
findings suggest that individuals with depression are unable to adequately sustain a 
response toward positive stimuli; this anomaly in brain activity patterns may represent 
an actual loss in reward value across time.  This may interfere with depressed 
individuals’ ability to sustain positive mood across time in everyday life, making it more 
probable—given their negative schemas and hypersensitivity to negative stimuli—that a 
negative mood can take hold and be maintained.  
Thus, anhedonia not only encompasses a reduction in the capacity to subjectively 
experience pleasure from activities that most people find enjoyable (e.g., a good meal 
or a good book), but also is characterized by an inability to sustain neural activity in 
regions that are thought to support positive affect over time (Tomarken and Keener, 
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1998).  In another neuroimaging study, Keller et al. (2013) assessed trait anhedonia via 
a questionnaire in healthy adults without prior history of Axis I diagnoses and had them 
rate the pleasantness of various pieces of music.  Individuals who initially endorsed 
higher trait anhedonia levels rated the music pieces as less pleasant; greater trait 
anhedonia was also associated with reduced activity in various brain regions that are 
integral to reward processing, such as the NAcc. 
Together, these findings suggest that anhedonia in depressed patients involves 
neural networks that are involved in: a) negative schemas, b) general reward 
processing, and c) the ability to sustain a neural response over time following positive 
stimulation, with disruptions in the underlying fronto-striatal networks resulting in 
difficulties in responding appropriately to positive stimuli.  
Anhedonia also has a very social component, in that individuals who are anhedonic 
may (or may not) show deficits in the number and quality of their positive relationships.  
Indeed, there is a subtype of anhedonia termed “social anhedonia” that is characterized 
by a reduced ability to derive pleasure from social situations.  However, given that the 
broader construct of anhedonia, which includes both social and non-social aspects, has 
not yet been investigated using repetitive transcranial magnetic stimulation (rTMS), one 
aim of the current work was to determine how anhedonia proper (encompassing both 
social and non-social aspects of the construct), may relate to a particular aspect of 
social anhedonia (i.e., response to smiling faces) that we chose to measure using a 
facial emotion recognition task.  
The human face conveys detailed information about the emotional state of other 
people, and we interpret others’ emotions in part by analyzing facial displays at both 
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conscious and unconscious levels.  Here, our interest was in how depressed people 
read the happy facial displays of other people.  We conceptualize this activity—
subjective interpretation of pleasure on the face of another human being—as one 
narrow proxy for how people may take in and experience joy themselves.  Indeed, 
researchers have already identified an association between the ability to accurately 
read happy facial expressions and the experience of anhedonia (broadly construed).  
For example, the presence of anhedonia has been linked to a slowed ability to 
accurately identify positive facial emotions (Vrijen et al., 2016), which may, in turn, 
relate to a reduced subjective experience of positive emotion in response to the joy of 
another human being (generally a rewarding event under normal circumstances).   
Furthermore, there is a probable relationship between the ability to experience 
pleasure as a result of seeing a smiling face and the ability to discriminate among 
positive faces eliciting varying intensities. In fact, although it may be easy to read a 
frank smile and derive pleasure from it, it may be more difficult for individuals to read 
and subjectively experience pleasure in response to a slight smile.  Here, it is 
hypothesized that individuals who are genetically or biologically prone to accurately 
perceive subtle positive emotion may be less vulnerable to anhedonic symptoms, 
whereas individuals who are poor at this particular ability may be more likely to 
experience anhedonia. 
Efforts to combat the deleterious effects of depression have primarily focused on 
how to decrease sadness. Furthermore, the use of antidepressant medications, 
including SSRIs, has resulted in inconsistent findings, and these medications often fail 
to address anhedonic symptoms and amotivation in patients with MDD (Nutt et al., 
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2007; Shelton & Tomarken, 2001).  Behavioral Activation (BA), a psychotherapeutic 
approach that aims to increase engagement in adaptive activities and to solve problems 
that limit an individual’s access to rewards, has been commonly used to treat 
depression symptoms overall; yet, the research in the use of BA as a therapeutic 
method to ameliorate symptoms of anhedonia is inconsistent (Strauss, 2013).  Given 
inconsistencies in the literature regarding the efficacy of currently available treatments 
for depression, there is an increasing demand to identify and test the efficacy of 
alternative treatment modalities that may prove to be more efficient in addressing 
specific symptoms such as anhedonia.  rTMS represents a novel treatment that could 
potentially address these concerns. 
1.1 Depression and Anhedonia 
A diagnosis of MDD, as stated in the Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5), requires the presence of either a depressed mood or a 
loss of interest/pleasure that contributes to a change from prior functioning (DSM-5, 
2013).   Previous studies have estimated that more than two-thirds of all individuals 
diagnosed with MDD experience clinically significant levels of anhedonia (Buchwald & 
Rudick-Davis, 1993). The occurrence and manifestation of anhedonia in depressed 
individuals can be affected by a variety of factors such as race, ethnicity, and 
socioeconomic status (SES); Liu and Tronick (2014) found a greater likelihood for 
Hispanic, African-American, and Asian/Pacific Islander women to endorse symptoms of 
postpartum anhedonia than White women.  However, after accounting for SES, 
postpartum anhedonia was more likely to be reported by Asian/Pacific Islanders than 
members of any other racial group (Liu & Tronick, 2014). 
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The cognitive model of depression proposed by Aaron Beck (1979) is grounded in 
the concept of the “cognitive triad,” in which the depressed individual tends to have 
negative views of him/herself, to interpret ongoing experiences in a negative way, and 
to have negative views about the future.  Consistent with these theories, depressed 
individuals tend to exhibit a predilection to attend to, remember, and process negative 
stimuli in their environment more efficiently than positive stimuli that contradict their 
schemas (Blaney, 1986; Clark & Teasdale, 1982; Kuiper & Derry, 1982).In Disner et 
al.’s (2011) cognitive model of depression (Figure 1), depressed self-referential 
schemas in a vulnerable individual trigger biased attention, biased processing, and 
biased memory of internal and external stimuli. The depressed individual filters 
perceived information in a manner that over-represents the schema-consistent elements 
of the experience.  This biased focus toward schema-related elements in the 
environment, in turn, maintains depressive symptoms. The presence of depressive 
symptoms continues to strengthen and validate the vulnerable individual’s negative 
schema, thus reinforcing the cycle of biased processing of perceived experiences.  
 Importantly, the depressive cognitions and negatively-biased worldviews central 
to Beck’s cognitive model of depression are often accompanied by symptoms of 
anhedonia and thoughts of hopelessness (Beck et al., 2003).  Though models have 
varied across time, the most current models suggest that a complex neural circuit 
mediates the processing of hedonic information and emotional stimuli.  Indeed, reduced 
activity in many areas of the prefrontal cortex have been implicated in anhedonia, with 
abnormal activity observed in regions such as the dorsolateral prefrontal cortex 
(DLPFC), ventromedial prefrontal cortex (VMPFC), and orbitofrontal cortex (OFC) (Der-
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Avakian & Markou, 2011). The reward-processing neural circuitry recruits inputs and 
outputs from both cortical (i.e., VMPFC, DLFC) and subcortical structures (i.e., anterior 
cingulate cortex (ACC), NAcc), and disruptions and abnormal activity in these neural 
circuits can result in anhedonia-like symptoms and hedonic deficits (Der-Avakian & 
Markou, 2011). 
Addressing negative biases and cognitions alone does not generally bring positive 
emotions online. Increasing research suggests that treatment of depression should 
involve not only dismantling negative schemas and the cognitive triad, but also directly 
intervening to modulate the positive affect system in the brain. These different systems 
can be activated separately, and currently available treatments may be more or less 
efficacious for one or the other aspect of emotionality.  For example, previous research 
has already identified associations among anhedonia, trait emotionality (i.e., positive 
and negative mood), and social functioning. Blanchard et al. (1998) used multiple 
questionnaires to assess anhedonia, positive and negative affectivity, and overall social 
functioning in individuals with schizophrenia.  They found a negative correlation 
between anhedonia and trait positive affect.  Additionally, individuals with greater 
anhedonia reported greater negative affect and poorer social functioning than controls 
(Blanchard et al., 1998). Given that anhedonia is considered a trans-diagnostic 
symptom, it offers a meaningful avenue for research in MDD samples as well.   
Another study used a mediation analysis to demonstrate a link between social 
anhedonia and social functioning by assessing activity in brain regions associated with 
Theory of Mind (ToM), or the ability to explain and predict other people’s mental states.  
Individuals who experienced greater social anhedonia exhibited hypoactivation in the 
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medial prefrontal cortex and impaired activity in the ToM neural circuitry. These 
anomalies likely contributed to a hampered ability to understand and reason about the 
mental states of others in everyday life (Dodell-Feder et al., 2014). These studies 
highlight the negative effects of anhedonia, which not only contribute to a decreased 
response to pleasurable rewards, but also negatively impact people’s ability to function 
in social settings.  
 
Figure 1.1. Information processing in the cognitive model of depression proposed by 
Disner et al. (2011) 
1.2 Facial Emotion Recognition 
An important bottom-up process that plays a crucial role in vicarious emotional 
processing is the ability to detect emotional valence in facial expressions. Facial 
expressions help convey emotionally salient information about an individual’s internal 
state; they also help us communicate emotions to others, which facilitates appropriate 
social behavior (Knutson, 1996).  Although the interpretations of different facial 
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expressions may vary across cultural groups, the detection of emotions from facial 
expressions is a universal skill observed among members of both literate and illiterate 
cultures (Ekman & Friesen, 1971; Ekman et al., 1987).    
The ability to recognize, decode, and discriminate among emotional facial 
expressions develops with age.  Whereas correct identification of happiness, sadness, 
and anger from facial expressions develops early in childhood, the ability to identify 
facial expressions of fear, disgust, and surprise continues to develop over the course of 
late childhood and adolescence (Lawrence, Campbell, & Skuse, 2015). The ability to 
accurately recognize facial expressions predicts likeability among peers and social 
competence through later childhood and adolescence  (Izard et al., 2001; Miller et al., 
2005; Mostow, Izard, Fine, & Trentacosta, 2002).  Individuals interpret human faces to 
avoid conflict, predict the attitudes of other people, and to monitor and appropriately 
respond to social interactions with others (Hess, Kappas, & Scherer, 1988; Salovey & 
Mayer, 1990). This process may be disrupted in the context of depression. In particular, 
depressed individuals, with their negatively biased internal schema, who display a 
predisposition toward heightened processing of negative stimuli and reduced 
processing of positive stimuli in their environment, may also exhibit a response bias 
when attending to faces eliciting negative emotions compared to faces that display 
positive emotions. 
Indeed, individuals with MDD show difficulties in the efficient and accurate 
recognition of both positive and negative emotions in faces.  Specifically, Surguladze et 
al. (2004) showed that—compared with healthy volunteers—depressed patients 
demonstrated a bias away from the accurate identification of happy and positive 
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expressions. Similarly, Demenescu et al. (2010) found, in a meta-analytic study, that 
patients with MDD exhibited significant biases in overall emotional facial identification.  
Another study found that depressed patients, compared to healthy controls, were slower 
and more inaccurate at recognizing neutral faces; they also reported a higher incidence 
of sad responses to neutral faces.  These findings further highlight the tendency among 
depressed individuals to misinterpret neutral emotions as negative (Leppanen et al., 
2004; Gur et al., 1992).  Further, Joorman and Gotlib (2006) found that individuals with 
MDD required significantly greater intensity of positive emotion to accurately identify 
happy faces compared to faces that displayed emotions such as fear and sadness, 
indicating reduced reward responsiveness. Taken together, the evidence suggests that 
individuals with MDD struggle to identify emotions from facial stimuli accurately.  
 Differences in the speeded identification of emotion from facial stimuli have also 
been identified between patients with MDD and healthy controls. In one recent 
prospective study, reduced speed in identifying happy faces relative to sad faces 
prospectively predicted the onset of depressive disorder and symptoms of anhedonia in 
adolescence (Vrijen et al., 2016). This finding adds credence to the hypothesis that 
individuals are faster at identifying stimuli that are congruent with their emotional state in 
the moment; therefore, individuals who are at risk for MDD, who display symptoms of 
anhedonia, or who are currently diagnosed with MDD all are likely to react faster to 
negative stimuli (sad faces) than to positive stimuli (happy faces). However, current 
research looking at the speeded responses to facial stimuli is scarce, and what remains 
to be more fully elucidated is whether response speed varies across different intensities 
of positive stimuli. 
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Given the importance of speeded processing of affective information in the ability 
to respond appropriately to environmental and social demands, depressed individuals 
who exhibit a bias in speeded processing of positive stimuli of various intensities may 
also produce more errors in emotion recognition, which could negatively impact their 
ability to function normally in social contexts in everyday life (Gross, 1998; Gollan et al., 
2008).  Research focused on the speeded identification of positive facial expression in 
patients with MDD is sparse. Further research is warranted to help us better understand 
mechanisms that underlie identification of positive facial emotion in individuals with 
MDD.  This understanding could also help improve emerging treatments. 
1.3 Repetitive Transcranial Magnetic Stimulation  
Relapse in treated individuals with MDD, even following acute interventions such 
as electroconvulsive therapy (ECT), is common (Coppen et al., 1981; Grunhaus, 
Dolberg, & Lustig, 1995). To address this problem, clinicians and researchers have 
begun to explore new pharmacologic and nonpharmacologic approaches, including 
rTMS, to ameliorating depression (Mantovani et al., 2012).  Several meta-analyses of 
placebo-controlled trials have indicated that rTMS is effective in providing acute, 
clinically significant antidepressant effects; further, additional studies have investigated 
the safety and efficacy of TMS as an acute antidepressant form of treatment (Mantovani 
et al., 2012; Moreines, McClintock & Holtzheimer, 2010).   
Studies have also investigated neural mechanisms of depression and the 
antidepressant effects of rTMS.  For example, research has strongly implicated the 
DLPFC, particularly the left DLPFC, in the pathophysiology of depression (Davidson, 
2004; Taylor & Liberzon, 2007). Specifically, the lateral prefrontal cortex has been 
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implicated in eudemonia (i.e. well-being; Heller et al., 2013) and anhedonia (Light et al., 
2011) during attempts to up-regulate (DLPFC) or down-regulate (ventrolateral prefrontal 
cortex (VLPFC)) positive affect. It is thought that hypo-activation of the DLPFC in 
particular relates to the reduced experience of positive emotions (Davidson, 2004; 
Heller et al. 2013), whereas increased VLPFC activity relates to the suppression of 
positive emotion often seen in depressed individuals (Light et al., 2011).  
Prior research also indicates that those individuals with MDD who respond to 
antidepressant treatment showed increases in activity in DLPFC pre- to post-treatment 
(Taylor & Liberzon, 2007; Brody et al., 2001).  Thus, because depression is associated 
with a decrease in left DLPFC activity, studies have successfully used high-frequency 
rTMS to induce greater cerebral blood flow in this region to induce a clinical 
antidepressant effect (Nahas et al., 2001; Gross et al., 2007; Rumi et al., 2005).  
Further, Avery et al. (2006) found that the clinical effects of rTMS to the left DLPFC 
increased with the duration of the treatment, highlighting a linear effect between the 
number of rTMS sessions and depression score reduction. Importantly, the efficacy of 
rTMS to the left DLPFC may also lie in its indirect effects on other brain regions; for 
example, it may initiate or enhance negative connectivity between DLPFC and the a) 
subgenual cingulate (Taylor et al., 2018) and b) frontopolar prefrontal cortex (Downar & 
Daskalakis, 2013).  Regardless of the pathways along which it operates, we 
hypothesize that rTMS targeting the left DLPFC is a promising region approach to 
anhedonia reduction in depressed individuals.  
Further, advancement in individualizing rTMS treatment to particular patients may 
spring from specifically investigating the effectiveness of rTMS on one or more specific 
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aspects of anhedonia.  Given that the two key symptoms present in depression are 
anhedonia and/or sad mood, determining the effectiveness of rTMS on anhedonia in 
particular (versus global depression symptomatology), and a very specific aspect of 
anhedonia at that—positive emotion recognition in human facial stimuli—may help 
identify rTMS treatment protocols that are better or more poorly suited to target this 
specific symptom. Indeed, the efficacy of rTMS varies depending on site of stimulation, 
and not all patients who receive the treatment respond. Therefore, by using a novel 
behavioral task to look for distinct relationships between performance on the task and 
rTMS treatment response at the symptom level (rather than looking for a relationship 
simply between self-reported anhedonia and response to rTMS treatment), we may 
provide a means by which to ascertain whether this aspect of the disorder changes pre- 
to post- rTMS.  
In the current study, individuals with MDD underwent a series of either active or 
sham rTMS sessions targeting the left DLPFC and completed a novel behavioral task 
that required each participant to identify various intensities of positive emotion in a 
series of human faces, pre- to post-treatment.  Previous studies have identified a 
significant correlation between increased accuracy in recognition of happy faces and 
clinical improvement after six-weeks of antidepressant medication treatment (Tranter et 
al., 2009).  Although multiple studies have yielded evidence of improvements in the 
accurate identification of positive emotions in facial stimuli post-treatment, few studies 
have examined associations between the accurate identification of varying intensities of 
positive emotion and the effects of treatment on how quickly people accurately detect 
happiness in human faces.  Considering that depressed individuals demonstrate a 
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predilection toward identifying negatively-valenced faces quickly and are typically less 
accurate and slower in identifying faces that express positive emotion, successful 
treatment of both of these positive and negative affective symptoms of depression may 
help shift these individuals’ emotional predispositions and result in better, more accurate 
interpretations of positive emotion in human faces post-treatment (Leppanen et al., 
2004; Gur et al., 1992).  Additionally, as previous research has suggested that 
individuals with MDD are typically faster at detecting negative faces than positive faces, 
treatment with rTMS may result in faster response speeds to positive emotion in faces if 
rTMS is able to influence neural mechanisms associated with positive affectivity 
(Suslow & Junghanns, 2001).  Given the utility of rTMS as an innovative and low-risk 
technique to alleviate symptoms of depression, the proposed study aims to identify 
beneficial effects of rTMS on the left DLPFC on the speed and accuracy with which 
depressed people identify positive emotion in human faces, a skill that is often impaired 
in anhedonic individuals and thus may serve as one behavioral marker of the symptom.   
1.4 Specific Aims and Hypotheses 
Despite research on the utility of rTMS as a therapeutic technique to decrease 
general symptoms of depression, questions remain regarding its long-term efficacy, as 
well as its effects on the perceptual biases of individuals with MDD.  The current study 
serves to address this issue by observing whether multiple sessions of rTMS will have 
an effect on an individual’s performance on a task that requires accurate and speeded 
identification of positive emotion.  As rTMS has been previously shown to provide 
antidepressant effects for individuals with MDD (Mantovani et al., 2012), and given that 
depressed individuals tend to exhibit a negative processing bias in interpreting neutral 
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faces as sad and are typically slower, less accurate, and require higher intensity happy 
faces to accurately categorize human faces as happy, we hypothesized that rTMS to 
the left DLPFC would impact the speed and accuracy of identification of positive 
emotions in human faces.  This hypothesis is based on prior literature and the idea that 
individuals who are more anhedonic have two problems that may make it difficult for 
them to attend to and interpret positive information in their environment: 1) a negative 
processing bias, and 2) an intensity bias, such that it takes exposure to more intense 
positive stimuli for them to register and interpret a conveyed positive emotion.  We were 
most interested the intensity bias in our investigation of rTMS to the left DLPFC. 
 The current study focused on a sample of adults diagnosed with MDD and used 
a novel behavioral measure of positive emotional identification (i.e. the “Happy Faces” 
task) to investigate the effectiveness of rTMS on this social aspect of anhedonia.  The 
study could have direct impacts on the fields of psychiatry, clinical neuropsychology, 
and positive psychology; further, this study will contribute to the growing body of work 
on the role of emotional processing in depression. 
 Specific Aim 1  1.4.1
Determine the effect of rTMS to the left dorsolateral prefrontal cortex on the 
speeded identification of various intensities of happy emotional faces. 
Hypothesis 1: Individuals in the active rTMS group would be faster in the identification 
of faces, specifically to low-intensity faces on the Happy Faces Task, by post-treatment 
than individuals who underwent the sham treatment. 
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 Specific Aim 2 1.4.2
Determine the effect of rTMS to the left dorsolateral prefrontal cortex on the 
accurate identification of various intensities of happy emotional faces. 
Hypothesis 1: Individuals who underwent active treatment will show statistically 
significant improvement in their performance at post-treatment relative to pre-treatment 
(compared to individuals in the sham group).  In particular, we expected patients to 
make gains in accurately identifying low intensity happy faces (relative to high intensity 
happy faces, where we anticipated no gains pre-post treatment).   
2       METHODS 
2.1 Procedures 
2.1.1  Participants 
Twenty-six adults (Mage = 45.21, SD = 11.21, 63% women) were recruited for the 
study.  Of these adults, 97% identified themselves as non-Hispanic white; one 
participant self-identified as Asian.  To be enrolled, participants had to be between the 
ages of 22 and 65 years, and to meet DSM-IV diagnostic criteria for MDD, as assessed 
with the Mini-International Neuropsychiatric Interview (M.I.N.I.) (Sheehan et al., 1998).  
In addition, they had to obtain a score of 18 or higher on the Montgomery-Asberg 
Depression Rating Scale (MADRS), a 9-item questionnaire that includes questions 
about sadness, inner tension, reduced sleep, an inability to feel, pessimistic and suicidal 
thoughts, and concentration difficulties. Finally, participants were required to have 
experienced failure of at least one antidepressant treatment at adequate dose/duration 
or have failed to achieve adequate dose/duration due to intolerable side effects, and to 
have been on a current stable dose of medication for at least four weeks prior to rTMS 
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therapy. Medications had to be maintained on a stable dosage for one month prior to 
and during the double-blinded phase. Potential participants were excluded if they 
reported presence of bipolar disorder (I/II), obsessive-compulsive disorder, post-
traumatic stress disorder, any psychosis, or serious suicidal ideation/behavior; previous 
repetitive Transcranial Magnetic Stimulation (rTMS) treatment; previous ECT, and 
contra-indications to rTMS or MRI.  Table 1 shows the means and standard deviations 
for age, number of medications used, and MADRS prescreen scores for each group.   
Table 1 
 
Demographics and Participant Characteristics  
 Active rTMS Group Sham rTMS Group 
Gender   
     n       12        14 
     % Female       75        57.1 
     % Male       25        42.9 
Age       45.25        44.78 
     SD       10.88        10.71 
Number of Medications         2.75          2.28 
     SD         1.48          1.33 
MADRS Scores        24.5        21.64 
     SD         5.38          3.67 
     Range       18-33        18-25 
SHAPS Scores**       31.83        35.21 
     SD         3.79          4.92 
     Range       28-38        28-43 
Note: MADRS = Montgomery-Asberg Depression Rating Scale;  
SHAPS = Snaith Hamilton Pleasure Scale 
**Based on Franken et al. (2007), a score equal to or greater than 29 indicates clinically 
significant anhedonia using the 2-standard deviation rule 
2.1.2 Measures 
The Montgomery-Asberg Depression Rating Scale (MADRS), a 9-item 
questionnaire that includes questions about sadness, inner tension, reduced sleep, an 
inability to feel, pessimistic and suicidal thoughts, and concentration difficulties. The 
score range is 0-27 points, and a score at baseline on the MADRS of 18 or greater was 
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required for study entry.  The MADRS has been found to have high internal consistency 
(Cronbach’s alpha = 0.85), construct validity, and concurrent validity relative to other 
depression screeners such as the Beck Depression Inventory – II (BDI-II) and the 
Hamilton Depression Scale (Kjærgaard et al., 2014; Davidson et al., 1986). 
 The Snaith-Hamilton Pleasure Scale (SHAPS) is a 14-item self-report scale that 
assesses the respondent’s ability to feel pleasure in response to stimuli that typically 
elicit positive emotions.  The SHAPS covers four domains: interests/pastimes, social 
interaction, sensory experience, and food/drink.  The inter-item reliability for this test is 
0.857 and higher scores are indicative of greater anhedonia (Snaith et al., 1995; 
Nakonezny et al., 2015).   Published normative data indicate that healthy controls who 
are not anhedonic exhibit a mean score of 20.4 (Franken et al., 2007), whereas the 
sample of confirmed depressed patients had a mean score of 34.4 (Franken et al., 
2007).  Using a cut-off of two standard deviations above the mean of healthy controls to 
indicate clinically significant anhedonia, these data suggest that a score of 29 or greater 
indicates clinically significant anhedonia.   
The Happy Faces Task is designed to ascertain levels of anhedonia (Mirabito et 
al., 2019).  During the task, patients are asked to look at human faces (balanced by 
gender) evincing varying degrees of positive emotion.  The task consists of 20 low-
intensity trials and 33 high-intensity trials presented in random order, with 22 neutral 
trials interspersed.  When the task was developed, researchers selected stimulus faces 
from the well-validated Cohn-Kanade dataset, which includes hundreds of images of 
human faces expressing neutral and varying degrees of spontaneous positive emotion 
(Cohn, Ziochower, Lien & Ambadar, 1999; Ambadar, Cohn & Reed, 2009). They then 
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identified faces that elicited “low-intensity” positive emotions (i.e., subtle smiles) or 
“high-intensity” positive emotions (i.e., frank smiles) (Mirabito et al., 2019). Specifically, 
faces that showed only zygomaticus activity (facial muscles that control mouth-based 
actions of smiling) were identified as low intensity, and faces that showed both 
orbicularis (facial muscles that control the eyelid region) and zygomaticus activity were 
identified as high intensity.  Whereas some task paradigms use facial stimuli that span a 
broad range of discrete emotions, the Happy Faces Task focuses simply on the 
presence or absence of positive emotion of any type.  
During the Happy Faces Task, participants were instructed to indicate by button 
press whether any positive emotion was present on the face they were viewing in “yes” 
or “no” format.  Importantly, the face remained on the screen until the participant made 
a response and their reaction time was recorded.  Task duration was approximately 10 
minutes for each participant.   In a recently published study that used the Happy Faces 
Task during fMRI scanning, findings yielded evidence that the Happy Faces Task is a 
valid measure of consummatory anhedonia and may have clinical utility in anhedonic 
populations (Mirabito et al., 2019). 
2.1.3   Procedure 
The protocol was a sham-controlled, randomized, double-blind study.  A research 
assistant conducted a psychiatric assessment (the MADRS, a MINI-Structured Clinical 
Interview for DSM-IV disorders, and a psychiatric interview) with each potential 
participant before study enrollment.  Patients who met study inclusion criteria then 
provided informed consent to take part in the full study.  They then underwent an 
assessment process, which included the completion of the SHAPS and the pre-
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treatment Happy Faces Task.  Participants also underwent MRI scanning to identify 
target locations for rTMS treatment.  All patients eventually received rTMS treatment, 
but at study entry, they were randomly assigned to a sham treatment or active treatment 
group. 
Following screening and assessment, subjects entered phase one of the study.  
In this blinded phase, subjects had 20 sessions of rTMS therapy or sham treatment, 
delivered on five days per week for four weeks by a licensed psychiatrist.  rTMS 
treatments were delivered at 10 Hz frequency at 120% of motor threshold, with 3000 
pulses/session to the left DLPFC at a location determined by neuronavigation from each 
participant’s initial Magnetic Resonance Imaging (MRI) session.  TMS was delivered 
with the NeuroStar XPLOR system in research mode.  Whereas the coil in the active 
rTMS group was active, the sham coil, which was identical in shape and weight to the 
active coil, did not deliver any magnetic energy.  A speaker on the coil gantry delivered 
a 10Hz pulsed sound that mimicked acoustic characteristics of the active coil.  At the 
end of phase one, five taper TMS sessions over two weeks were performed for those in 
the active arm and five sham taper sessions were delivered over two weeks to sham 
participants (phase two).  Participants from both groups completed the Happy Faces 
Task at the end of their respective treatment.  Subjects who received sham stimulation 
had the option of receiving active TMS in the second, open-label phase of the study.   
2.1.4  Analytic Plan 
 In order to determine the effect of rTMS to the left DLPFC on the speeded and 
accurate identification of various intensities of happy emotional faces over time, we 
conducted two repeated-measures ANCOVAs for each dependent variable. A repeated-
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measures ANCOVA was used given our interest in examining group differences in 
performance as a function of time (pre-treatment and post-treatment) and intensity of 
the happy face (i.e., high, low, neutral). In our analyses, accuracy and reaction speed 
on the Happy Faces Task served as dependent variables, while group membership (i.e., 
active vs. sham treatment) was included as the independent variable. 
ANCOVA, rather than ANOVA, was a preferable approach because we included 
a number of covariates in our analysis. First, age and sex were included, given 
evidence from epidemiological studies that these factors such as age and sex can 
influence the prevalence of MDD, such that depressive symptoms are more common in 
females in young adulthood and less common in patients aged 65 years (Gallo et al., 
1994; Bebbington et al., 1998; Stordal et al., 2001).  Second, we included indices of 
depression severity (i.e., number of medication, MADRS score) as covariates in the 
analysis to control for the possibility that effects of treatment on task performance might 
be attributable to baseline depression severity (Nakonezny et al, 2010). Koenig et al. 
(1998) found that the number of medications taken, akin to illness severity, was 
significantly related to depression severity in an elderly population.  Finally, in order to 
control for the possibility that effects of treatment on task performance might be 
attributable to baseline subjective experience of anhedonia (which may not be an 
accurate indicators of their behaviorally observed/measured anhedonia), we included 
pretest SHAPS scores as an additional covariate.  
 We also decided to run two separate ANOVAs looking at group effects on both 
dependent variables (i.e., accuracy and reaction speed) with the exclusion of these 
covariates.  Given the small sample size and low power in the study, we conducted 
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these analyses in order to see if the exclusion of these variables would have any effect 
on the statistical output.   
In additional exploratory analyses, we also ran two ANCOVAs without including 
the baseline levels of anhedonia (SHAPS score) as a covariate in order to increase the 
statistical power of the analysis and to examine whether baseline self-reported SHAPS 
scores would meaningfully affect performance on the Happy Faces Task.  
Prior to conducting the main analyses, we examined the data for potential 
sources of biases.  First, we generated boxplots to identify outliers in the data.  We 
identified three univariate outliers in the dataset; we therefore winsorized the data by 
replacing outliers with the next highest score that was not an outlier.  We then 
conducted Levene’s tests for each of the dependent variables in order to check for 
assumptions of homogeneity of variances; results were not significant for any variables, 
indicating that the assumption of homogeneity of variances was met.  Finally, we 
conducted Mauchly’s test to assess for the presence of sphericity (the variation within 
the experimental conditions is roughly equal). Violation of sphericity may create a loss 
of power and an inaccurate test statistic.  Results of the Mauchly tests were not 
significant, which indicates that data met the assumptions of sphericity. 
3    RESULTS 
The patients’ pre- and post-treatment performance based on group membership 
on speeded reaction times (ms) and accuracy scores relative to the corresponding facial 
stimuli (low-intensity, neutral, or high-intensity) are presented in Table 2.   
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Table 2 
Participant Performance on Reaction Speed and Accuracy to Different Intensities of 
Happy Faces based on Group and Type of Facial Stimuli 
 Group 
 Active Sham 
Measure Mean SD Mean SD 
Rx to low-intensity 1  2083.00 870.22 1661.63 916.78 
Rx to low-intensity 2  1646.88 476.92 1354.30 386.47 
Acc to low-intensity 1      13.08     3.92     12.07     4.98 
Acc to low-intensity 2      13.92     4.08     12.71     4.75 
Rx to high-intensity 1  1266.86 563.17 1068.12 385.49 
Rx to high-intensity 2  1200.88 346.49   976.60 180.16 
Acc to high-intensity 1      31.42     2.07     31.43     2.56 
Acc to high-intensity 2      32.17     1.34     32.43     1.02 
Rx to neutral 1  1729.68 746.87 1569.67 851.45 
Rx to neutral 2  1785.17 468.71 1450.25 591.49 
Acc to neutral 1 18.17    2.48     18.50     2.14 
Acc to neutral 2 18.17    2.25     17.50     3.32 
Note: 1 = pre; 2 = post; Rx = Reaction Time, Acc = Accuracy 
 
3.1  Reaction Speed  
 
As shown in Table 3, results from a repeated-measures one-way ANCOVA, with 
reaction speed as the dependent variable and number of medications, age, SHAPS 
scores, MADRS scores, and gender included as covariates, yielded no evidence of 
statistically significant main effects of treatment group, time, or face type.  The 
interaction between time and group membership was also non-significant.   
Results did, however, indicate a significant effect of pre-treatment SHAPS scores 
on reaction speed (F(1,20) = 4.76, p = .04, ηp2 = .19).  A correlation matrix presented in 
Table 4 shows that pre-treatment SHAPS scores were negatively correlated with 
reaction times to low intensity faces prior to treatment and neutral faces post-treatment.  
In other words, contrary to our predictions, participants who endorsed higher levels of 
anhedonia on the SHAPS responded faster to low intensity and neutral faces.  
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Table 3 
 
Repeated-Measures ANCOVA with Reaction Speed as the Dependent Variable 
Tests of Within-Subjects Effects 
 Type III Sum 
of Squares df F p ηp
2 
Time   20610.49 1  .04 .85 .00 
Facial Intensity 853393.08 1       2.67 .08 .12 
Time * Group 337679.74 1 .58 .46 .03 
Tests of Between-Subjects Effects 
 Type III Sum 
of Squares 
df F p ηp2 
Intercept 5340569.89 1 5.60 .03 .22 
Gender  185402.72 1   .19 .66 .01 
MADRS 1687844.76 1 1.77 .20 .08 
Medications   290780.49 1   .31 .59 .02 
SHAPS   450113.63 1 4.76  .04* .19 
Group     49348.42 1   .05 .82 .00 
Error 19071053.80 20    
*p < .05 
Table 4 
Correlation Matrix (SHAPS and Rx) 
Correlation Matrix 
Measure  SHAPS Score 
Rx to low intensity 1 Pearson Correlation -.44* 
 Sig. (2-tailed) .03 
Rx to low intensity 2 Pearson Correlation -.37 
 Sig. (2-tailed) .06 
Rx to neutral 1 Pearson Correlation -.38 
 Sig. (2-tailed) .06 
Rx to neutral 2 Pearson Correlation -.49* 
 Sig. (2-tailed) .01 
Rx to high intensity 1 Pearson Correlation -.30 
 Sig. (2-tailed) .14 
Rx to high intensity 2 Pearson Correlation -.27 
 Sig. (2-tailed) .18 
Note: 1 = pre; 2 = post; Rx = Reaction Time 
*Correlation is significant at the .05 level (2-tailed) 
 
Main effects of group membership and time remained non-significant at a 
significance threshold of p = .05 when covariates were excluded (see Table 5).  
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However, there was a significant main effect of facial intensity (F(2, 48) = 21.41, p < .01, 
ηp2 = .55). Consistent with what we expected, the participants, regardless of group, 
reacted the slowest when asked to identify faces that elicited low intensity positive 
emotions and responded the fastest to high intensity faces.  Pairwise comparisons 
among the three face types can be seen in Table 6.  As shown in Figure 3.1, 
participants’ reaction times to neutral faces were marginally faster than their reaction 
speed to low intensity faces. The interaction between time and group membership was 
also non-significant.  
Table 5 
 
Repeated-Measures ANOVA with Reaction Speed as the Dependent Variable 
Tests of Within-Subjects Effects 
 Type III Sum 
of Squares 
df F p ηp2 
Time    1002638.02 1   1.82 .19 .07 
Facial Intensity   9823864.74 2 21.41 <.01* .55 
Time * Group         5526.00 1     .01 .92 .00 
Tests of Between-Subjects Effects 
 Type III Sum of 
Squares 
df F p ηp2 
Intercept  340945398.00 1 314.08 .00 .93 
Group     2867968.81 1     2.64  .12 .10 
Error    26053151.20 24    
*p < .05 
Table 6  
Pairwise Comparisons Among Facial Intensities (Reaction Speed) 
Pairwise Comparisons 
Facial Intensity Mean (ms) Comparison Mean Differences 
Standard 
Error p 
Low Intensity        1686.45 High Intensity    558.34   86.77  <.01* 
  Neutral     52.76   65.73   .43 
Neutral        1633.69 Low Intensity     -52.76   65.73   .43 
  High Intensity    505.58   86.38  <.01* 
High Intensity        1128.11 Low Intensity  -558.34   86.77  <.01* 
  Neutral  -505.58   86.38  <.01* 
*p < .05 
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Figure 3.1 Performances on Reaction Times Based on Group Membership and Intensity 
of Facial Stimuli 
 
3.2  Accuracy 
Results of a repeated-measures one-way ANCOVA, with accuracy as the 
dependent variable and number of medications, age, pre-treatment SHAPS scores, 
MADRS scores, and gender included as covariates, indicated no statistically significant 
main effects of treatment group, time, or face type.  The interaction between time and 
group membership was also non-significant.  No other significant main effects or 
interactions were observed (see Table 7). 
Table 7 
 
Repeated-Measures ANCOVA with Accuracy as the Dependent Variable 
Tests of Within-Subjects Effects 
 Type III Sum 
of Squares df F p ηp
2 
Time     .89 1     .22  .64 .01 
Facial Intensity 89.12 1   2.77  .07 .12 
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Time * Group   1.30 1     .33  .58 .02 
Tests of Between-Subjects Effects 
 Type III Sum 
of Squares 
df F p ηp2 
Intercept  672.211 1 59.29 .00 .75 
Gender  25.19 1   2.22 .15 .10 
MADRS    1.19 1     .11 .75 .01 
Medications  17.08 1   1.51 .23 .07 
SHAPS  16.49 1   1.45 .24 .07 
Group    5.93 1     .52 .48 .03 
Error      226.76 20    
 
 Similarly, when a repeated-measures one-way ANOVA was conducted with the 
exclusion of the covariates, results indicated no statistically significant main effects of 
group or time; however, there was a significant difference in performance in the 
accurate identification of different intensities of positive faces (F(1,24) = 309.65, p < .05, 
ηp2 = .93) (See Table 8).  All participants, regardless of group membership, were the 
most accurate when asked to identify high intensity positive faces, and they performed 
the worst when asked to accurately identify the faces eliciting low intensity positive 
emotions (Figure 3.2). Table 9 shows pairwise contrasts that indicate significant 
differences in accuracy across all facial comparisons.  No other significant main effects 
or interactions were observed. The interaction between time and group membership 
was also non-significant.   
Table 8 
 
Repeated-Measures ANOVA with Accuracy as the Dependent Variable 
Tests of Within-Subjects Effects 
 Type III Sum 
of Squares df F p ηp
2 
Time      5.34 1        1.29  .27 .05 
Facial Intensity      9889.00 1    309.65 <.01* .93 
Time * Group        .95 1         .23  .64 .01 
Tests of Between-Subjects Effects 
 
 
28 
 Type III Sum of 
Squares 
df F p ηp2 
Intercept       68150.06 1 5875.95 .00 .99 
Group           5.57 1         .48  .50 .02 
Error           278.36 24    
*p < .05 
Table 9 
Pairwise Comparisons Among Facial Intensities (Accuracy) 
Pairwise Comparisons 
Facial Type Mean Comparison Mean Differences 
Standard 
Error p 
Low Intensity        12.95 High Intensity   -18.91   .59 <.01* 
  Neutral    -5.14 1.10 <.01* 
Neutral        18.08 Low Intensity     5.14 1.10 <.01* 
  High Intensity -13.78   .55 <.01* 
High Intensity        31.86 Low Intensity  18.91   .59 <.01* 
  Neutral  13.78   .55 <.01* 
* p < .01 
 
 
 
 
Figure 3.2 Performances on Accuracy Based on Group Membership and Intensity of 
Facial Stimuli 
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3.3  Exploratory Analysis 
When SHAPS score was removed as a covariate, results of the initial analyses 
did not change.  The repeated-measures ANCOVA conducted with reaction time as the 
dependent variable indicated no significant main effects of group, time, or facial intensity 
(Table 10).  However, as shown in Table 11, although the repeated-measures ANCOVA 
with accuracy as the dependent variable indicated no significant main effects of group 
membership or time, there was a significant main effect of facial intensity on the 
participant’s ability to accurately respond (F(1,21) = 5.71, p = .01, ηp2 = .21).  Similarly 
as before, participants were the most accurate when asked to quickly identify positive 
emotions in high intensity faces; however, they performed significantly worse when 
asked to identify positive emotions in more ambiguous faces (e.g., low intensity, neutral 
faces).Further, there were no significant time by group interactions on either reaction 
time or accuracy.  
Table 10 
Repeated-Measures ANCOVA on Reaction Time (Without SHAPS) 
Tests of Within-Subjects Effects 
 Type III Sum of 
Squares df F p ηp
2 
Time 367970.90 1 .64 .43 .03 
Facial Intensity     6251.02 2 .02 .98 .00 
Time * Group 165588.43 1 .29 .60 .01 
Tests of Between-Subjects Effects 
 Type III Sum of 
Squares 
df F p Partial Eta 
Squared 
Intercept   997266.03 1   .89 .36 .04 
Gender 1040687.38 1   .93 .35 .04 
MADRS 1165552.62 1 1.04 .32 .05 
Meds   108670.35 1   .10 .76 .01 
Group   888897.95 1   .79 .38 .04 
Error    23611167.40 21    
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Table 11 
Repeated-Measures ANCOVA on Accuracy (Without SHAPS) 
Tests of Within-Subjects Effects 
 Type III Sum of 
Squares df F p ηp
2 
Time 5.23 1 1.25 .28 .06 
Facial Intensity       182.17 1 5.71  .01* .21 
Time * Group .07 1 .02 .90 <.01 
Tests of Between-Subjects Effects 
 Type III Sum of 
Squares 
df F p Partial Eta 
Squared 
Intercept        1485.29 1   128.23 < .01 .86 
Gender   16.84 1       1.45 .24 .07 
MADRS     2.34 1         .20 .66 .01 
Meds     7.57 1         .65 .43 .03 
Group   15.34 1       1.32 .26 .06 
Error          243.25 21    
 
DISCUSSION 
This study of the effects of rTMS treatment on how quickly and accurately adults 
with MDD identified positive emotions in an array of faces extends previous research on 
the utility of rTMS to combat symptoms of depression, particularly when it is 
administered to the left DLPFC (Davidson, 2004; Taylor & Liberzon, 2007).  Given 
previous research on the beneficial effects of rTMS for acute depression, we 
hypothesized that rTMS treatment would have an ameliorating effect on one 
behaviorally-measured aspects of anhedonia.  Specifically, we predicted that depressed 
participants who underwent 20 active high frequency rTMS sessions would react faster 
and more accurately in identifying positive emotions, especially low-intensity positive 
faces, on the Happy Faces Task than would participants who underwent sham 
treatment.   
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We did not find any significant treatment effects on the participants’ ability to 
quickly and accurately identify different facial intensities on the Happy Faces Task.  Yet, 
as predicted, we found that individual’s speed and accuracy varied as a function of 
stimulus face emotional intensity.  We had anticipated that depressed individuals would 
more accurately identify faces that elicited low intensity positive emotions than faces 
showing high intensity positive emotions.  Results from the analyses were consistent 
with this idea, and participants were significantly better at identifying faces that exhibited 
evident positive emotions than more subtle faces that displayed more ambiguous 
expressions (neutral and low intensity faces), suggesting that depressed individuals 
may demonstrate difficulties in quickly deciphering between neutral faces and faces that 
exhibit low levels of positive emotions.  
Interestingly, we found a significant effect of SHAPS score on participants’ reaction 
speed to the different facial stimuli, such that individuals who endorsed greater levels of 
anhedonia were faster in identifying low intensity faces and neutral faces.  This 
observation deviated from our hypotheses, in which we assumed that more anhedonic 
individuals would be slower in processing happiness in faces, especially faces eliciting 
low intensity positive emotions.  Subjective factors, such as alertness, level of attention 
and focus, and impulsivity may have played a role in these findings. Although 
depression-related anhedonia has been associated with reduced levels of arousal, 
research focusing on attentional processes in individuals with anhedonia is sparse (Amr 
& Volpe, 2013).  However, given the small sample size and resulting low power of the 
study, caution is warranted in interpreting this finding unless it is replicated. Future 
studies focused on anhedonia and facial expression identification would benefit from 
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recruiting larger samples and from including measures to assess subjective levels of 
attention/alertness and impulsivity.  
Overall, these findings indicate that although rTMS to the left DLPFC has been 
shown to provide moderate general antidepressant effects for individuals with 
depression, it may not induce changes in the behaviorally measured aspect of social 
anhedonia presented here (i.e., identification of positive emotion in others’ faces).  
Given that all patients were also taking psychoactive medications at the time of the 
study (on a stable dose), it is possible that these patients may not have demonstrated a 
measurable change in performance with active rTMS because symptoms were 
dampened or relieved by concurrent psychoactive medication usage.  Future studies 
should better rule out this possibility by excluding participants that are medicated at the 
time of the study or comparing medicated and unmedicated individuals.  
Current neuroimaging models of depression suggest that disruptions in the 
interactions among emotion-regulating regions such as the DLPFC, VLPFC, 
dorsomedial prefrontal cortex (DMPFC), VMPFC, and the dorsal and ventral ACC 
contribute to the onset of depressive symptoms (Seminowicz et al., 2004; Greicius et 
al., 2007; Price & Drevets, 2012; Johnstone et al., 2007; Davey et al., 2012). Further, 
researchers propose that different clinical subtypes and depression profiles based on 
symptomatology may depend on underlying patterns of network disruption (Downar et 
al., 2014).  Multiple studies have postulated that dopamine (DA) pathway impairment—
with circuitry coursing through the ACC, amygdala, and the prefrontal cortex—
contributes to the prevalence of anhedonia (Martin-Soelch, 2009).  In the 
“endophenotype concept” model of MDD (Figure 4.1), Gorwood (2008) suggests that 
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anhedonia is an intermediate endophenotype, defined as a heritable mechanism that 
bridges the gap between clinical phenotypes and genetics, that results from a deficit in 
reward processing, which can be influenced by either a genetic predisposition or the 
presence of environmental risk factors (Gottesman, Hon, & Gould, 2003).   
Other evidence suggests that hedonic processing is not a unitary construct but 
rather consists of both anticipatory (motivation to pursue an impending reward) and 
consummatory (in-the-moment aspects of pleasure) phases; reduced activations and 
disruptions in brain areas that process either consummatory and/or anticipatory aspects 
of reward processing (such as prefrontal subregions, thalamus, insula, and the ventral 
striatum) can result in an anhedonic presentation (Sherdell et al., 2012; Höflich et al., 
2019).  Nestler and Carlezon (2006) suggested that the mesolimbic dopamine system, 
which is dependent on dopaminergic connections between subcortical areas of the 
brain such as the NAcc and ventral tegmental area (VTA) of the midbrain, contribute to 
the interpretation of reward and hedonic processing; disruptions of this system can also 
result in anhedonia-like symptoms.  The mesolimbic dopaminergic system also includes 
projections from the VTA to the medial PFC, and a reduction or interruption of dopamine 
release along this pathway can also result in amotivation and an anhedonic profile 
(Drevets, Price & Furey, 2008).   
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Figure 4.1. The role of anhedonia as an endophenotype between risk factors and 
depression as proposed by Gorwood et al. (2008) 
 
Downar et al. (2014) posited that different treatment modalities, whether invasive 
or noninvasive, could be used to target specific brain regions that are involved within 
these neural systems in order to intervene more efficaciously. Invasive techniques such 
as high-frequency deep brain stimulation (DBS) of subcortical brain regions, such as the 
subgenual cingulate gyrus and the NAcc, have been incorporated as an effective 
technique for reducing depression-like symptoms in treatment-resistant depression 
(Mayberg et al., 2005; Delaloye & Holtzheimer, 2014).  With respect to noninvasive 
techniques, current studies primarily use rTMS to reduce depressive symptoms.  
However, given the current results, questions remain open regarding the efficacy of 
rTMS treatment targeting the left DLPFC for adequately addressing the social aspect of 
anhedonia measured in this study.   
While the treatment of depression with active rTMS has consistently centered on 
the DLPFC, emerging evidence suggests that other cortical brain regions may play a 
central role in depression.  For example, a neuroimaging study looking at the effects of 
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rTMS found that the VMPFC, an area that is often linked with reward learning and 
interpretation of rewards, acts as a “bottleneck” region in depressed patients with 
anhedonia, who demonstrate poorer connectivity between areas of the mesolimbic 
dopaminergic system (i.e. VTA and left caudate nucleus).  This observation suggests 
that VMPFC may be a potential future target for effective rTMS treatment of hedonic 
processing (Downar et al., 2014).  Another study found that abnormal VMPFC and 
striatal activity was present in anhedonic populations when they responded to positive 
stimuli; anhedonic participants who found it difficult to respond happily to positive stimuli 
displayed a greater VMPFC response, which is the reverse of the pattern often 
observed in healthy adults (Keedwell et al., 2005).  The effects on anhedonic symptoms 
of rTMS to the VMPFC region might thus be worthwhile to examine.      
 Another brain region in which to explore the utility of rTMS is the VLPFC, a 
cortical area that has been shown to exhibit abnormal patterns of hyperactivity in 
depressed individuals during positive affect inhibition. In one study, individuals who 
were respondent to antidepressant medication and showed the greatest reduction in 
anhedonia after 8 weeks of treatment exhibited lower levels of VLPFC activity when 
asked to suppress positive affect (Light et al., 2011).  Other studies found that 
depressed patients exhibited greater activity in the VLPFC while processing positive 
stimuli, which may result in the experience of excessive negative affect and an overall 
reduction to experience pleasure and positive affect (Light et al., 2001; Keedwell et al., 
2005; Kumari et al., 2003).  Given the role of VLPFC in hedonic processing and the 
experience of positive affect, rTMS treatment targeting the suppression of activity in the 
VLPFC in depressed individuals may be a potential alternative to pursue. Moreover, 
 
 
36 
researchers could compare the effects of rTMS to the DLPFC and VMPFC on both self-
reported and behaviorally measured anhedonia. 
 An important limitation of this study is that the sample sizes in both groups were 
very small, which may have obscured significant relationships. It will be helpful for future 
researchers to replicate this study using a larger sample, which will increase the study’s 
power and increase the likelihood of detecting true relationships.  Another limitation of 
this study is the lack of racial diversity in the sample; there was only one Asian 
participant in the sample, and the rest were Caucasian.  Studies have shown that the 
diagnosis and treatment of depression in both adult populations can be influenced by 
racial and ethnic differences; this relationship is mediated by the presence of life factors 
such as socioeconomic status, social support, and exposure to poverty that vary across 
ethnic and racial groups (U.S. DHHS, 2001; Plant & Sachs-Ericsson, 2004; Holahan et 
al., 1999).  Thus, the presentation and severity of depression and anhedonia may 
manifest differently as a function of racial and ethnic disparities (Dunlop et al., 2003; 
Akincigil et al., 2012).  Inclusion of participants from a variety racial/ethnic backgrounds 
would be useful for evaluating the generalizability of rTMS treatment effects.  
 Of note, anhedonia can manifest in different ways and can include physical, 
social, appetitive, and consummative features (Ho & Sommers, 2014).  Whereas 
physical anhedonia refers to decreases in ability to experience pleasure from physical 
activities (i.e. eating, sex), social anhedonia refers to reduction in ability to experience 
pleasure with loved ones and friends (Blanchard et al. 2011; Reise et al., 2011; Ho & 
Sommers, 2014).  Studies have found that individuals experiencing anhedonia can have 
intact anticipatory pleasure and a deficit in consummatory pleasure, the reverse trend, 
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or deficits in both (Martin et al., 2011; Strauss et al., 2011; Der-Avakian & Marou, 2012).  
Thus, although the results of the study implied that rTMS treatment did not have any 
beneficial effect on the depressed individuals’ facial processing skills, which may tap 
aspects of consummatory and/or social pleasure, these results cannot decisively rule 
out potential treatment effects to other facets of anhedonia, including physical or 
anticipatory pleasure.  Future studies might further explore the utility of rTMS to the left 
DLPFC for treating other facets of anhedonia.  
 In conclusion, our results suggest that rTMS treatment to the left DLPFC in 
depressed patients does not significantly improve speed of or accuracy in identifying 
positive emotions in facial stimuli.  Hedonic processing of positive stimuli in one’s 
environment, whether personal or social, requires one to learn and assess its reward 
value. Given that these skills are often compromised in anhedonic adults, future studies 
might examine how rTMS modulation of activity in regions the brain—such as the 
VMPFC—that support reward learning may reduce both anhedonic and more traditional 
depressive symptoms.   
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